1. In this randomized controlled trial, glyburide was not non-inferior in terms of the composite rate of macrosomia, neonatal hypoglycemia, and hyperbilirubinemia compared with subcutaneous insulin. 2. Women taking glyburide had better glycemic control and were more likely to prefer glyburide for subsequent pregnancies but also had higher rates of maternal and neonatal hypoglycemia. Evidence […]